eedq has been researched along with oxadiazoles in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gopalakrishnan, M; Triggle, DJ | 1 |
Burton, MJ; Jones, BJ; Middlemiss, DN; Price, GW; Watson, JM | 1 |
2 other study(ies) available for eedq and oxadiazoles
Article | Year |
---|---|
Irreversible modification of the voltage-sensitive calcium channel by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Topics: Adrenergic alpha-Antagonists; Animals; Calcium; Calcium Channels; Guinea Pigs; Isradipine; Male; Muscle Contraction; omega-Conotoxin GVIA; Oxadiazoles; Peptides, Cyclic; Quinolines | 1990 |
GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors.
Topics: Adenylyl Cyclases; Alkylating Agents; Animals; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Logistic Models; Oxadiazoles; Piperazines; Quinolines; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |